annual operating expenses:
$5.09B+$795.10M(+18.49%)Summary
- As of today (August 18, 2025), VRTX annual total operating expenses is $5.09 billion, with the most recent change of +$795.10 million (+18.49%) on December 31, 2024.
- During the last 3 years, VRTX annual operating expenses has risen by +$1.20 billion (+30.93%).
- VRTX annual operating expenses is now at all-time high.
Performance
VRTX Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$1.41B+$9.30M(+0.67%)Summary
- As of today (August 18, 2025), VRTX quarterly total operating expenses is $1.41 billion, with the most recent change of +$9.30 million (+0.67%) on June 30, 2025.
- Over the past year, VRTX quarterly operating expenses has dropped by -$4.38 billion (-75.72%).
- VRTX quarterly operating expenses is now -75.72% below its all-time high of $5.79 billion, reached on June 30, 2024.
Performance
VRTX quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
VRTX Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +18.5% | -75.7% |
| 3 y3 years | +30.9% | +60.2% |
| 5 y5 years | +111.1% | +129.3% |
VRTX Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +46.2% | -75.7% | +60.2% |
| 5 y | 5-year | at high | +111.1% | -75.7% | +129.3% |
| alltime | all time | at high | >+9999.0% | -75.7% | +5481.9% |
VRTX Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $1.41B(+0.7%) |
| Mar 2025 | - | $1.40B(+1.4%) |
| Dec 2024 | $5.09B(+18.5%) | $1.38B(+9.0%) |
| Sep 2024 | - | $1.26B(-78.2%) |
| Jun 2024 | - | $5.79B(+378.9%) |
| Mar 2024 | - | $1.21B(+1.5%) |
| Dec 2023 | $4.30B(+23.4%) | $1.19B(+5.8%) |
| Sep 2023 | - | $1.13B(-2.9%) |
| Jun 2023 | - | $1.16B(-12.9%) |
| Mar 2023 | - | $1.33B(+38.9%) |
| Dec 2022 | $3.48B(-10.4%) | $958.00M(+4.0%) |
| Sep 2022 | - | $920.80M(+5.0%) |
| Jun 2022 | - | $877.30M(+7.2%) |
| Mar 2022 | - | $818.30M(-13.6%) |
| Dec 2021 | $3.89B(+49.7%) | $946.70M(+36.8%) |
| Sep 2021 | - | $691.94M(-56.8%) |
| Jun 2021 | - | $1.60B(+147.2%) |
| Mar 2021 | - | $648.05M(-4.5%) |
| Dec 2020 | $2.60B(+7.7%) | $678.43M(+0.1%) |
| Sep 2020 | - | $678.05M(+10.7%) |
| Jun 2020 | - | $612.73M(-2.9%) |
| Mar 2020 | - | $630.79M(-6.6%) |
| Dec 2019 | $2.41B(+22.2%) | $675.29M(-5.6%) |
| Sep 2019 | - | $715.62M(+33.6%) |
| Jun 2019 | - | $535.59M(+10.1%) |
| Mar 2019 | - | $486.54M(-17.7%) |
| Dec 2018 | $1.97B(+8.4%) | $591.09M(+26.4%) |
| Sep 2018 | - | $467.81M(-1.5%) |
| Jun 2018 | - | $474.83M(+7.8%) |
| Mar 2018 | - | $440.36M(-0.2%) |
| Dec 2017 | $1.82B(+23.0%) | $441.46M(-22.6%) |
| Sep 2017 | - | $570.56M(+36.9%) |
| Jun 2017 | - | $416.70M(+7.7%) |
| Mar 2017 | - | $386.89M(+8.0%) |
| Dec 2016 | $1.48B(+7.9%) | $358.36M(-5.3%) |
| Sep 2016 | - | $378.43M(-1.1%) |
| Jun 2016 | - | $382.66M(+6.0%) |
| Mar 2016 | - | $361.07M(-11.4%) |
| Dec 2015 | $1.37B(+18.2%) | $407.48M(+17.8%) |
| Sep 2015 | - | $346.06M(+8.7%) |
| Jun 2015 | - | $318.25M(+8.5%) |
| Mar 2015 | - | $293.28M(+7.9%) |
| Dec 2014 | $1.16B(-6.2%) | $271.82M(+5.5%) |
| Sep 2014 | - | $257.68M(-14.7%) |
| Jun 2014 | - | $302.23M(-1.0%) |
| Mar 2014 | - | $305.28M(-6.0%) |
| Dec 2013 | $1.24B(+3.3%) | $324.80M(+2.7%) |
| Sep 2013 | - | $316.38M(-3.8%) |
| Jun 2013 | - | $328.98M(+5.8%) |
| Mar 2013 | - | $310.97M(-3.9%) |
| Dec 2012 | $1.20B(+8.1%) | $323.56M(+8.6%) |
| Sep 2012 | - | $297.85M(-5.2%) |
| Jun 2012 | - | $314.06M(+2.1%) |
| Mar 2012 | - | $307.52M(-0.3%) |
| Dec 2011 | $1.11B(+34.3%) | $308.32M(+2.9%) |
| Sep 2011 | - | $299.71M(+12.7%) |
| Jun 2011 | - | $265.91M(+20.2%) |
| Mar 2011 | - | $221.28M(-0.8%) |
| Dec 2010 | $825.22M(+21.3%) | $223.16M(+5.0%) |
| Sep 2010 | - | $212.53M(+13.0%) |
| Jun 2010 | - | $188.09M(+10.0%) |
| Mar 2010 | - | $170.98M(+7.3%) |
| Dec 2009 | $680.47M(+10.1%) | $159.42M(-1.5%) |
| Sep 2009 | - | $161.89M(-1.4%) |
| Jun 2009 | - | $164.11M(-0.5%) |
| Mar 2009 | - | $164.94M(+2.9%) |
| Dec 2008 | $618.20M | $160.24M(+7.4%) |
| Sep 2008 | - | $149.21M(+0.9%) |
| Jun 2008 | - | $147.85M(+14.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | $128.71M(-2.0%) |
| Dec 2007 | $597.78M(+39.2%) | $131.34M(-8.5%) |
| Sep 2007 | - | $143.53M(-6.0%) |
| Jun 2007 | - | $152.66M(+6.9%) |
| Mar 2007 | - | $142.79M(+20.9%) |
| Dec 2006 | $429.57M(+46.8%) | $118.11M(+12.5%) |
| Sep 2006 | - | $104.95M(+6.2%) |
| Jun 2006 | - | $98.81M(+20.8%) |
| Mar 2006 | - | $81.83M(+10.5%) |
| Dec 2005 | $292.53M(+24.9%) | $74.08M(+10.1%) |
| Sep 2005 | - | $67.30M(+5.7%) |
| Jun 2005 | - | $63.64M(+5.7%) |
| Mar 2005 | - | $60.22M(-14.3%) |
| Dec 2004 | $234.30M(-1.9%) | $70.24M(+30.7%) |
| Sep 2004 | - | $53.74M(+6.8%) |
| Jun 2004 | - | $50.33M(+13.7%) |
| Mar 2004 | - | $44.27M(-8.5%) |
| Dec 2003 | $238.72M(-0.3%) | $48.40M(-15.2%) |
| Sep 2003 | - | $57.10M(+6.8%) |
| Jun 2003 | - | $53.45M(-12.7%) |
| Mar 2003 | - | $61.22M(-3.7%) |
| Dec 2002 | $239.39M(+21.6%) | $63.55M(0.0%) |
| Sep 2002 | - | $63.55M(+6.1%) |
| Jun 2002 | - | $59.89M(+3.1%) |
| Mar 2002 | - | $58.12M(+5.6%) |
| Dec 2001 | $196.80M(+36.9%) | $55.02M(+9.8%) |
| Sep 2001 | - | $50.11M(+43.6%) |
| Jun 2001 | - | $34.90M(+12.2%) |
| Mar 2001 | - | $31.10M(+128.8%) |
| Dec 2000 | $143.79M(+37.5%) | $13.60M(-46.9%) |
| Sep 2000 | - | $25.59M(+5.1%) |
| Jun 2000 | - | $24.35M(+4.5%) |
| Mar 2000 | - | $23.29M(-189.2%) |
| Dec 1999 | $104.60M(+28.5%) | -$26.11M(-223.5%) |
| Sep 1999 | - | $21.14M(-8.4%) |
| Jun 1999 | - | $23.09M(+13.1%) |
| Mar 1999 | - | $20.41M(+27.1%) |
| Dec 1998 | $81.40M(+22.2%) | $16.06M(+236.5%) |
| Sep 1998 | - | $4.77M(+14.6%) |
| Jun 1998 | - | $4.16M(+28.0%) |
| Mar 1998 | - | $3.25M(-82.6%) |
| Dec 1997 | $66.60M(+8.6%) | $18.70M(-7.4%) |
| Sep 1997 | - | $20.20M(+42.3%) |
| Jun 1997 | - | $14.20M(+6.8%) |
| Mar 1997 | - | $13.30M(-48.8%) |
| Dec 1996 | $61.30M(+17.2%) | $26.00M(+134.2%) |
| Sep 1996 | - | $11.10M(-9.8%) |
| Jun 1996 | - | $12.30M(+3.4%) |
| Mar 1996 | - | $11.90M(+3.5%) |
| Dec 1995 | $52.30M(+19.4%) | $11.50M(+1.8%) |
| Sep 1995 | - | $11.30M(-35.4%) |
| Jun 1995 | - | $17.50M(+45.8%) |
| Mar 1995 | - | $12.00M(-0.8%) |
| Dec 1994 | $43.80M(+43.1%) | $12.10M(+9.0%) |
| Sep 1994 | - | $11.10M(0.0%) |
| Jun 1994 | - | $11.10M(+14.4%) |
| Mar 1994 | - | $9.70M(-7.6%) |
| Dec 1993 | $30.60M(+84.3%) | $10.50M(+28.0%) |
| Sep 1993 | - | $8.20M(+26.2%) |
| Jun 1993 | - | $6.50M(+25.0%) |
| Mar 1993 | - | $5.20M(+13.0%) |
| Dec 1992 | $16.60M(+56.6%) | $4.60M(+7.0%) |
| Sep 1992 | - | $4.30M(+230.8%) |
| Jun 1992 | - | $1.30M(-63.9%) |
| Mar 1992 | - | $3.60M(+20.0%) |
| Dec 1991 | $10.60M(+65.6%) | $3.00M(+15.4%) |
| Sep 1991 | - | $2.60M(0.0%) |
| Jun 1991 | - | $2.60M |
| Dec 1990 | $6.40M | - |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual total operating expenses?
- What is the all time high annual operating expenses for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual operating expenses year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly operating expenses year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual total operating expenses?
The current annual operating expenses of VRTX is $5.09B
What is the all time high annual operating expenses for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual total operating expenses is $5.09B
What is Vertex Pharmaceuticals Incorporated annual operating expenses year-on-year change?
Over the past year, VRTX annual total operating expenses has changed by +$795.10M (+18.49%)
What is Vertex Pharmaceuticals Incorporated quarterly total operating expenses?
The current quarterly operating expenses of VRTX is $1.41B
What is the all time high quarterly operating expenses for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly total operating expenses is $5.79B
What is Vertex Pharmaceuticals Incorporated quarterly operating expenses year-on-year change?
Over the past year, VRTX quarterly total operating expenses has changed by -$4.38B (-75.72%)